Social Rewarding: Amount of References of Revisions (unweighted, directly from DB)

From WikiPathways

Jump to: navigation, search
Select order by      
Weight on number of references     Show author     Show date

Showing below up to 50 results starting with #4,551.

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

  1. [R116669] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  2. [R123953] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  3. [R126330] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  4. [R126355] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  5. [R129567] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  6. [R129568] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  7. [R129569] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  8. [R129570] Homo sapiens:Triacylglyceride synthesis (0.00 points)
  9. [R80883] Bos taurus:Cardiac hypertrophic response (0.00 points)
  10. [R105982] Bos taurus:Cardiac hypertrophic response (0.00 points)
  11. [R117483] Bos taurus:Cardiac hypertrophic response (0.00 points)
  12. [R140021] Bos taurus:Cardiac hypertrophic response (0.00 points)
  13. [R80884] Bos taurus:Blood clotting cascade (0.00 points)
  14. [R86998] Bos taurus:Blood clotting cascade (0.00 points)
  15. [R105964] Bos taurus:Blood clotting cascade (0.00 points)
  16. [R117481] Bos taurus:Blood clotting cascade (0.00 points)
  17. [R120913] Bos taurus:Blood clotting cascade (0.00 points)
  18. [R136906] Bos taurus:Blood clotting cascade (0.00 points)
  19. [R80886] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  20. [R89886] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  21. [R89887] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  22. [R105917] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  23. [R108105] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  24. [R117627] Bos taurus:TCA cycle nutrient use and invasiveness of ovarian cancer (0.00 points)
  25. [R80889] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  26. [R87243] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  27. [R87244] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  28. [R105930] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  29. [R117499] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  30. [R120497] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  31. [R128624] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  32. [R128628] Bos taurus:Drug induction of bile acid pathway (0.00 points)
  33. [R80892] Bos taurus:Lidocaine metabolism (0.00 points)
  34. [R92721] Bos taurus:Lidocaine metabolism (0.00 points)
  35. [R92722] Bos taurus:Lidocaine metabolism (0.00 points)
  36. [R92724] Bos taurus:Lidocaine metabolism (0.00 points)
  37. [R92725] Bos taurus:Lidocaine metabolism (0.00 points)
  38. [R106002] Bos taurus:Lidocaine metabolism (0.00 points)
  39. [R80893] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  40. [R105954] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  41. [R117565] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  42. [R137965] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  43. [R140143] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  44. [R140152] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  45. [R140153] Bos taurus:Nicotine activity on chromaffin cells (0.00 points)
  46. [R80895] Bos taurus:Target of rapamycin (TOR) signaling (0.00 points)
  47. [R97055] Bos taurus:Target of rapamycin (TOR) signaling (0.00 points)
  48. [R111150] Bos taurus:Target of rapamycin (TOR) signaling (0.00 points)
  49. [R116794] Bos taurus:Target of rapamycin (TOR) signaling (0.00 points)
  50. [R116795] Bos taurus:Target of rapamycin (TOR) signaling (0.00 points)

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

Views
Personal tools